Shopping Cart
Remove All
Your shopping cart is currently empty
Regdanvimab (Synonyms: T-P59, IN-006, IN006, CT-P59, CTP59)
Catalog No. T76851 Copy Product Info
🥰Excellent
Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection.
Regdanvimab
Copy Product Info🥰Excellent
Catalog No. T76851
Synonyms T-P59, IN-006, IN006, CT-P59, CTP59
Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection.
Regdanvimab
Cas No. 2444308-95-4
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $213 | In Stock | In Stock | |
| 5 mg | $562 | In Stock | In Stock | |
| 10 mg | $893 | - | In Stock | |
| 25 mg | $1,320 | - | In Stock | |
| 50 mg | $1,780 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:100% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection. |
| In vitro | Regdanvimab neutralizes the gamma, Delta, Epsilon, and Kappa variants of SARS-CoV-2 in cells. [1] |
| In vivo | Treatment with Regdanvimab (5, 20, 40, and 80 mg/kg, intrabitoneally injected) relieved respiratory symptoms and eliminated the virus in mice infected with the SARS-CoV-2 variant. [1] |
| Synonyms | T-P59, IN-006, IN006, CT-P59, CTP59 |
| Reactivity | Virus |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Spike RBD |
| Molecular Weight | 146.22 kDa |
| Cas No. | 2444308-95-4 |
| Isotype | Human IgG1 lambda1 |
| Recommended Isotype Control |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
Preview
Related Tags: buy Regdanvimab | purchase Regdanvimab | Regdanvimab cost | order Regdanvimab | Regdanvimab in vivo | Regdanvimab in vitro | Regdanvimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.